10-K/A

AMENDMENT NO. 1

Company: TENAX THERAPEUTICS, INC.
Filed: August 29, 2011
Period of Report: April 30, 2011
Accession Number: 0001354488-11-003139

View Document ↗ View on SEC.gov ↗